Journal of Drugs in Dermatology - Generic 750 mg levofloxacin for bacterial infections in adults
A first-time generic formulation of 750 mg levofloxacin tablets (Levaquin, Ortho-McNeil Pharmaceuticals, Inc.) has been approved by the FDA. Levofloxacin is a fluoroquinolone antibiotic and is currently indicated for various infections in adults including uncomplicated skin and skin structure infections.
Related Results
Levaquin approvalLevaquin doseNew indication for LevaquinOral solution levaquin approvedLevaquin tablets and oral solution
COPYRIGHT 2005 Journal of Drugs in Dermatology, Inc.
COPYRIGHT 2008 Gale, Cengage Learning
